Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of 131 I
摘要篇首: Patients with metastatic thyroid cancer (MTC) was routinely treated with a small dose of 131I before 1989. After that we have been switched to multiple courses of large dose 131I therapy. In this paper, the therapeutic result and its effect, in particular on bone marrow depression, pulmonary, parathyroid and salivary gland function as well as chromosome aberration1-3 were observed and reported.
更多相关知识
- 浏览125
- 被引11
- 下载4

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文